55 filings
8-K
OncoMed Pharmaceuticals Inc
23 Apr 19
Completion of Acquisition or Disposition of Assets
4:17pm
8-K
OncoMed Pharmaceuticals Inc
17 Apr 19
Submission of Matters to a Vote of Security Holders
3:26pm
8-K
OncoMed Pharmaceuticals Inc
15 Mar 19
OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights
7:03am
8-K
OncoMed Pharmaceuticals Inc
7 Mar 19
OncoMed Announces Fourth Quarter and Full Year 2018 Financial Results
4:10pm
8-K
OncoMed Pharmaceuticals Inc
28 Jan 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
itojm3z j41d
6 Dec 18
To be effected by anall-stock transaction plus issuance of Contingent Value Rights (“CVRs”); completion expected H1 2019
7:05am
8-K
r7j2 0f5n7n17p2k
1 Nov 18
OncoMed Announces Third Quarter 2018 Financial Results and Operational Highlights
4:07pm
8-K
puvr0l7hfm9u7e x9
17 Oct 18
Other Events
4:10pm
8-K
ep3bs
1 Oct 18
Departure of Directors or Certain Officers
12:00am
8-K
27d08xwxfjjo1
20 Sep 18
OncoMed Provides Update on Navicixizumab Partnership
8:05am
8-K
94uujkbe4 hec6y2
2 Aug 18
OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights
8:30am
8-K/A
ywy5bj89a9xcr2fsz41
27 Jun 18
Departure of Directors or Certain Officers
4:05pm
8-K
7chswke3xaz9 5xxc76
25 Jun 18
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
fy2cwa
8 May 18
OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights
4:06pm
8-K
xhsxt
19 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
0pkjx
8 Mar 18
OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
12:00am
8-K/A
dfjrhkf2b hjbm5
23 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
wwy046t9
31 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
m3486vc8jkelz1
4 Jan 18
OncoMed Provides 2018 Outlook and 2017 Year-End Cash Balance and Announces an Update on the Rosmantuzumab Program
12:00am
8-K
md0 ub2hxm41d6j
2 Nov 17
OncoMed Announces Third Quarter 2017 Financial Results and Operational Highlights
12:00am